In today’s market, distressed companies and assets are plentiful. Learn from experienced M&A veterans how best to take advantage of these situations. How do you buy distressed companies and stay healthy and profitable? What are the inherent risks? How do you manage the unknown liabilities and integration?
Panelists:
-
Jackson Craig, Managing Director, H.I.G. Capital
-
Charles R. Dougherty, Managing Director, BR Strategies, LLC
-
Richard L. Vieira, Co-Founder and Managing Partner, 2SV Capital, LLC
Related Insights
May 28, 2025
Health Care Law Today
The Intersection of AI, Digital Health, and the TCPA: What You Need to Know
Artificial intelligence (AI) is widely transforming digital health, including by automating certain patient communications. However, as…
May 28, 2025
Foley Viewpoints
Rethinking University Research: Innovating the Innovation Ecosystem to Support Life Sciences and Personalized Medicine
Personalized medicine—tailoring treatments to individual patients based on their genetic makeup, lifestyle, and environment—is…
May 27, 2025
Foley Ignite
Lost in Translation: Key Deal Points in European vs. U.S. M&A Transactions
After two decades practicing law in Silicon Valley and five formative years working on cross-border deals in Europe, I've come to…